Fascination About conolidine
Andy Chevigné and his team, RTI-5152-12 is postulated to raise the levels of opioid peptides that bind to classical opioid receptors inside the brain, resulting in heightened painkilling activity. The LIH-RTI research groups established a collaboration agreement and filed a joint patent application in December 2020.Conolidine CONOCB2™, that has